Cargando…
An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances
Thymic tumors are a group of rare mediastinal malignancies that include three different histological subtypes with completely different clinical behavior: the thymic carcinomas, the thymomas, and the rarest thymic neuroendocrine tumors. Nowadays, few therapeutic options are available for relapsed an...
Autores principales: | Tateo, Valentina, Manuzzi, Lisa, Parisi, Claudia, De Giglio, Andrea, Campana, Davide, Pantaleo, Maria Abbondanza, Lamberti, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066729/ https://www.ncbi.nlm.nih.gov/pubmed/33915954 http://dx.doi.org/10.3390/ph14040316 |
Ejemplares similares
-
Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
por: Tateo, Valentina, et al.
Publicado: (2020) -
Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020) -
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
por: Lamberti, Giuseppe, et al.
Publicado: (2018) -
Prophylactic cholecystectomy is not mandatory in patients candidate to the resection for small intestine neuroendocrine neoplasms: a propensity score-matched and cost-minimization analysis
por: Ingaldi, Carlo, et al.
Publicado: (2021) -
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
por: Brighi, Nicole, et al.
Publicado: (2023)